Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Tax Rate (2017 - 2025)

Historic Tax Rate for Ultragenyx Pharmaceutical (RARE) over the last 9 years, with Q3 2025 value amounting to 0.49%.

  • Ultragenyx Pharmaceutical's Tax Rate fell 2600.0% to 0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78%, marking a year-over-year decrease of 11500.0%. This contributed to the annual value of 0.52% for FY2024, which is 8200.0% down from last year.
  • Ultragenyx Pharmaceutical's Tax Rate amounted to 0.49% in Q3 2025, which was down 2600.0% from 0.83% recorded in Q2 2025.
  • Ultragenyx Pharmaceutical's Tax Rate's 5-year high stood at 2.92% during Q4 2023, with a 5-year trough of 2.63% in Q3 2022.
  • Moreover, its 5-year median value for Tax Rate was 0.37% (2022), whereas its average is 0.36%.
  • In the last 5 years, Ultragenyx Pharmaceutical's Tax Rate surged by 30400bps in 2023 and then tumbled by -39300bps in 2024.
  • Ultragenyx Pharmaceutical's Tax Rate (Quarter) stood at 0.02% in 2021, then crashed by -661bps to 0.12% in 2022, then surged by 2492bps to 2.92% in 2023, then tumbled by -135bps to 1.01% in 2024, then soared by 52bps to 0.49% in 2025.
  • Its Tax Rate stands at 0.49% for Q3 2025, versus 0.83% for Q2 2025 and 0.87% for Q1 2025.